Immunization Finance Toolkit : A Resource for Policy-Makers and Program Managers
Financing is a critical component of a sustainable Immunization program. The Immunization Financing Toolkit is a series of short briefs on different options for financing national immunization programs and vaccines. It is intended to serve as a res...
Main Authors: | , |
---|---|
Format: | Working Paper |
Language: | English en_US |
Published: |
World Bank, Washington, DC
2014
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/2010/12/20365312/immunization-finance-toolkit-resource-policy-makers-program-managers http://hdl.handle.net/10986/20784 |
Summary: | Financing is a critical component of a
sustainable Immunization program. The Immunization Financing
Toolkit is a series of short briefs on different options for
financing national immunization programs and vaccines. It is
intended to serve as a resource for program managers and
decision---makers in ministries of health, planning, and
finance. The Toolkit brings together the most up---to---date
knowledge on the characteristics of various types of=
financing mechanisms as well as information on how the
mechanisms are being implemented in practice, their
potential benefits, and their limitations. Where possible,
case studies on specific financing options are included. The
field of immunization financing continues to evolve and the
Toolkit will therefore be web---based and easily downloaded
from the internet. As a web---based tool, the Toolkit
contains links to other relevant websites for further
understanding. The Toolkit is also available on a CD Rom.
This version of the Toolkit is an update of the Immunization
Financing Options produced by the Global Alliance for
Vaccines and Immunization (GAVI Alliance) in 2001. Health
sector funding and management have evolved over the last
decade, making the previous document out---of---date. New
and innovative financing mechanisms to support immunization
and the health sector have been developed and the types and
costs of vaccines have changed. In addition, policy---makers
and development partners have become much more knowledgeable
about health financing. |
---|